ImmunityBio, Inc. (IBRX)
6.02
-0.05
(-0.82%)
USD |
NASDAQ |
Nov 13, 16:00
5.90
-0.12
(-1.99%)
Pre-Market: 09:06
ImmunityBio Total Assets (Quarterly) : 609.39M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 609.39M |
| June 30, 2026 | 628.50M |
| March 31, 2026 | 646.64M |
| December 31, 2025 | 501.90M |
| September 30, 2025 | 518.99M |
| June 30, 2025 | 402.08M |
| March 31, 2025 | 303.76M |
| December 31, 2024 | 382.93M |
| September 30, 2024 | 364.57M |
| June 30, 2024 | 444.32M |
| March 31, 2024 | 400.68M |
| December 31, 2023 | 504.45M |
| September 30, 2023 | 432.42M |
| June 30, 2023 | 291.23M |
| March 31, 2023 | 343.40M |
| December 31, 2022 | 362.36M |
| September 30, 2022 | 352.94M |
| June 30, 2022 | 317.72M |
| March 31, 2022 | 389.59M |
| December 31, 2021 | 468.91M |
| September 30, 2021 | 214.42M |
| June 30, 2021 | 246.30M |
| March 31, 2021 | 209.43M |
| December 31, 2020 | 151.86M |
| Date | Value |
|---|---|
| September 30, 2020 | 180.54M |
| June 30, 2020 | 196.16M |
| March 31, 2020 | 127.02M |
| December 31, 2019 | 143.12M |
| September 30, 2019 | 160.21M |
| June 30, 2019 | 175.70M |
| March 31, 2019 | 208.26M |
| December 31, 2018 | 181.95M |
| September 30, 2018 | 201.64M |
| June 30, 2018 | 211.43M |
| March 31, 2018 | 229.84M |
| December 31, 2017 | 250.44M |
| September 30, 2017 | 277.74M |
| June 30, 2017 | 301.62M |
| March 31, 2017 | 303.68M |
| December 31, 2016 | 317.50M |
| September 30, 2016 | 332.41M |
| June 30, 2016 | 342.94M |
| March 31, 2016 | 357.43M |
| December 31, 2015 | 366.85M |
| September 30, 2015 | 370.19M |
| June 30, 2015 | 132.56M |
| March 31, 2015 | 52.14M |
| December 31, 2014 | 60.00M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Moderna, Inc. | 13.47B |
| Sarepta Therapeutics, Inc. | 3.166B |
| Oncolytics Biotech, Inc. | 5.832M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.755B |
| Shareholders Equity (Quarterly) | -1.146B |
| Debt to Equity Ratio | -1.131 |
| Current Ratio | 4.270 |
| Net Debt Paydown Yield | -0.90% |